Discipline | Immunology |
---|---|
Language | English |
Edited by | Y. Kawakami, F.M. Marincola, K. Tsang, D.C. Wraith |
Publication details | |
History | 2009-present |
Publisher | Future Medicine |
Frequency | 16/year |
Open access | Hybrid |
Impact factor | 2.716 (2016) |
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt ) | |
ISO 4 | Immunotherapy |
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
CODEN | IMMUCO |
ISSN | 1750-743X (print) 1750-7448 (web) |
LCCN | 2009243240 |
OCLC no. | 495368971 |
Links | |
Immunotherapy is a peer-reviewed medical journal covering immunology and more specifically immunotherapy. It was established in 2009 and is published by Future Medicine. The founding editor-in-chief was Duc Hong Le. The current editors-in-chief are Y. Kawakami, F.M. Marincola, K. Tsang and D.C. Wraith.
Abstracting and indexing
The journal is abstracted and indexed in:
- Biological Abstracts
- BIOSIS Previews
- Chemical Abstracts
- Embase
- Index Medicus/PubMed/MEDLINE
- Science Citation Index Expanded
- Scopus
According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.716, ranking it 90th out of 150 journals in the category "Immunology".
References
- "Biological Abstracts - Journal List". Intellectual Property & Science. Thomson Reuters. Archived from the original on 2016-01-01. Retrieved 2015-05-12.
- ^ "Master Journal List". Intellectual Property & Science. Thomson Reuters. Archived from the original on 2017-09-26. Retrieved 2014-12-13.
- "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2014-12-13.
- "Journal titles covered in Embase". Embase. Elsevier. Retrieved 2015-05-12.
- "Immunotherapy". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-13.
- "Content overview". Scopus. Elsevier. Retrieved 2015-05-12.
- "Journals Ranked by Impact: Immunology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.